首页> 美国卫生研究院文献>Stem Cell Reports >Revealing Tissue-Specific SARS-CoV-2 Infection and Host Responses using Human Stem Cell-Derived Lung and Cerebral Organoids
【2h】

Revealing Tissue-Specific SARS-CoV-2 Infection and Host Responses using Human Stem Cell-Derived Lung and Cerebral Organoids

机译:使用人干细胞衍生的肺和脑细胞体揭示组织特异性SARS-COV-2感染和宿主反应

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

COVID-19 is a transmissible respiratory disease caused by a novel coronavirus, SARS-CoV-2, and has become a global health emergency. There is an urgent need for robust and practical in vitro model systems to investigate viral pathogenesis. Here, we generated human induced pluripotent stem cell (iPSC)-derived lung organoids (LORGs), cerebral organoids (CORGs), neural progenitor cells (NPCs), neurons, and astrocytes. LORGs containing epithelial cells, alveolar types 1 and 2, highly express ACE2 and TMPRSS2 and are permissive to SARS-CoV-2 infection. SARS-CoV-2 infection induces interferons, cytokines, and chemokines and activates critical inflammasome pathway genes. Spike protein inhibitor, EK1 peptide, and TMPRSS2 inhibitors (camostatafamostat) block viral entry in LORGs. Conversely, CORGs, NPCs, astrocytes, and neurons express low levels of ACE2 and TMPRSS2 and correspondingly are not highly permissive to SARS-CoV-2 infection. Infection in neuronal cells activates TLR3/7, OAS2, complement system, and apoptotic genes. These findings will aid in understanding COVID-19 pathogenesis and facilitate drug discovery.
机译:Covid-19是由新型冠状病毒,SARS-COV-2引起的可传染性呼吸系统疾病,并已成为全球健康紧急情况。迫切需要鲁棒和实用的体外模型系统来研究病毒性发病机制。在此,我们生成人诱导的多能干细胞(IPSC)的肺细胞体(LORG),脑细胞体(CORG),神经祖细胞(NPC),神经元和星形胶质细胞。含有上皮细胞,肺泡类型1和2,高表达ACE2和TMPRSS2的leorgs,并且允许SARS-COV-2感染。 SARS-COV-2感染诱导干扰素,细胞因子和趋化因子,并激活临理炎症途径基因。穗蛋白抑制剂,EK1肽和TMPRSS2抑制剂(CAMOSTAT / NAFAMOSTAT)阻止leor的病毒进入。相反,Corgs,NPC,星形胶质细胞和神经元表达低水平的ACE2和TMPRSS2,并且相应地对SARS-COV-2感染不太宽容。神经元细胞感染激活TLR3 / 7,OAS2,补体系统和凋亡基因。这些发现将有助于了解Covid-19发病机制并促进药物发现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号